Nautilus Biotechnology, Inc. · NASDAQ:NAUT
Perceptive Advisors LLC reported a 9.10% stake in Nautilus Biotechnology, Inc. (Schedule 13D/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Perceptive Advisors LLC reported a 9.10% stake in Nautilus Biotechnology, Inc., 11,634,211 shares, with active intent on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13D/A).
- Stake
- 9.10%
- Shares
- 11,634,211
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 9.10% | 11,634,211 |
| Joseph Edelman | 9.10% | 11,634,211 |
| Perceptive Life Sciences Master Fund, Ltd. | 9.10% | 11,468,351 |
| C2 Life Sciences LLC | 0.10% | 165,860 |
Source
Related
- Nautilus Biotechnology, Inc.
- Perceptive Advisors LLC
- Nautilus Biotechnology, Inc. shareholders
- Schedule 13D/A · Perceptive Advisors LLC · Jun 24, 2025
- Schedule 13D/A · Perceptive Advisors LLC · Jan 31, 2025
- Schedule 13D/A · Andreessen Marc L · Sep 11, 2026
- Schedule 13D/A · Andreessen Marc L · Aug 28, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 30, 2026
- Form 4 · AH Bio Fund II, L.P. · Jun 4, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 4, 2026